Sign in
BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)
Michael A. Singer, MD
Updates from the Field
2024
Hereditary Retinal Disease & Genetics Take-Home Panel
David Sarraf, MD
Annual Meeting Talks
2019
Retinitis Pigmentosa
Ginny Martinez
Retina Image Bank: Images of the Week
2017
Category: Imaging- Fundus Autofluorescence (FAF)